Fitch currently maintains an ’A’ rating for Lockheed Martin’s Long-Term Issuer Default Rating and unsecured debt, with a Stable outlook. The company’s Short-Term IDR and commercial paper program are ...

GAZA/CAIRO (Reuters) -The Al-Shaer family went to bed hungry at their home in Gaza City. An Israeli airstrike killed them in their sleep. The family - freelance journalist Wala al-Jaabari, her husband ...

Investors expect updates on Tesla’s robotaxi rollout, with a pilot launch planned for Austin by June 2025. Elon Musk may emphasize the progress and potential of Full Self-Driving (FSD), although ...

Investing.com -- In a note to clients on Wednesday, BTIG downgraded Unity shares to Sell from Neutral, arguing that the stock ...

Citi expects Celsius to benefit from accelerating sales in 2025, helped by both its core Celsius brand and the recently acquired Alani Nu, which is expanding distribution and product innovation. The ...

Investing.com -- Raymond James downgraded Roblox shares to Outperform from Strong Buy on Wednesday, citing a sharp run-up in ...

Investing.com -- Vox Royalty Corp. (NASDAQ: VOXR) stock rose 1.2% following regulatory approval for a major expansion at the Binduli North gold project in Western Australia, where the company holds an ...

Investing.com -- Ikena Oncology Inc (NASDAQ: IKNA) stock rose 4.8% following the announcement of Kristin Yarema, Ph.D. as the Chief Executive Officer of ImageneBio, the company to be formed after ...

Veea has engaged an unnamed placement agent to arrange the sale of securities on a "reasonable best efforts" basis. The company noted that there is no established public trading market for the ...

Investing.com -- Jefferies has initiated coverage on Galaxy Digital (TSX: GLXY) with a Buy rating and a $35 price target given a stable, long-term cash flows from its AI data center operations and a ...

The bioengineered tissue product was sold to a state-of-the-art medical complex on a major U.S. military base that serves approximately 200,000 active-duty personnel, retirees, and their families.

Investing.com -- Castle Biosciences Inc (NASDAQ: CSTL) stock surged 7.8% after the company announced that its DecisionDx-Melanoma test received Breakthrough Device designation from the U.S. Food and ...